• Aloclair gel is indicated to relieve the pain caused by aphthous mouth ulcers and other minor oral lesions
• Aloclair gel provides fast pain relief from chafing and irritation caused by braces and ill fitting dentures

• Aloclair gel works by forming an invisible barrier over the ulcer, protecting the exposed nerve endings (the barrier can not be felt once it is applied).

In the European Union, under the provisions of EEC Directive 93/42/EC Aloclair gel is considered a Class 1 Medical Device.  In the U.S.A., Aloclair gel is registered as a 510(k) OTC medical device.

Aloclair gel is protected by patents granted in the USA (US6828308) and Europe (EP1313489), Chile, China, New Zealand and South Africa.

Patents are pending in Argentina, Australia, Brazil, Canada, Croatia, Czech Rep., Hong Kong, Hungary, Indonesia, India, Jordan, Japan, South Korea, Mexico, Malaysia, Norway, Pakistan, Philippines, Poland, Russia, Thailand, Taiwan, Ukranian Rep, Venezuela and South Africa.

Marketing companies are required to sell Aloclair in key territories around the world.